Alibhai Imran Nizamudin 4
4 · Tvardi Therapeutics, Inc. · Filed Apr 21, 2025
Insider Transaction Report
Form 4
Alibhai Imran Nizamudin
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-04-17+182,320→ 182,320 totalExercise: $17.04Exp: 2035-04-16→ Common Stock (182,320 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on April 17, 2026, and the balance of the shares subject to the option shall vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous service through each applicable vesting date.